Thalidomide (Thalomid, Celgene) as a treatment for multiple myeloma
Approvable designations
Fast-track designations
Orphan drug designations
Recommendations against approval
Novo Nordisk Terminates Collaboration with Hims & Hers
June 23rd 2025The FDA had resolved the shortage of Wegovy in April, and telehealth providers were advised to stop selling compounded semaglutide products. Novo Nordisk said that Hims & Hers continues to offer these compounded drugs.
Read More